1. Home
  2. ICD-10-PCS Index
  3. Administration
  4. Physiological Systems and Anatomical Regions
  5. Introduction
  6. 3E0P3LZ
  • Version 2026
  • Billable Code

2026 ICD-10-PCS Procedure Code 3E0P3LZ

Introduction of Sperm into Female Reproductive, Percutaneous Approach

ICD-10-PCS Code:
3E0P3LZ
ICD-10-PCS Code for:
Introduction of Sperm into Fem Reprod, Perc Approach
Is Billable?
Yes - Valid for Submission
Code Navigator:

3E0P3LZ is a billable procedure code used to specify the performance of introduction of sperm into female reproductive, percutaneous approach. The code is valid for the year 2026 for the submission of HIPAA-covered transactions. The procedure code involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

3E0P3LZ PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is female reproductive.

Position Designation Character Label Procedures Notes
1 Section 3 Administration
2 Body System E Physiological Systems and Anatomical Regions
3 Operation 0 Introduction

Involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
4 BodySystem/Region P Female Reproductive  
5 Approach 3 Percutaneous

Involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
6 Substance L Sperm
7 Qualifier Z No Qualifier

Explanation:
The value Z is used for the seventh character to indicate that a specific qualifier does not apply to the procedure.

Convert to ICD-9-PCS

Below are the ICD-9=PCS code(s) that most closely match this ICD-10-PCS code, based on the General Equivalence Mappings (GEMs). This ICD-10-PCS to ICD-9-PCS crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.

ICD-9-PCS Code

Code: 6992

Approximate Flag: This is an approximate match. The ICD-9-PCS code reflects a close but not exact equivalent of the ICD-10-PCS procedure.

Other ICD-10-PCS Codes Used for Introduction Female Reproductive


  • 3E0P05Z Introduction of Adhesion Barrier into Female Reproductive, Open Approach

  • 3E0P304 Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach

  • 3E0P305 Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach

  • 3E0P30M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach

  • 3E0P328 Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach

  • 3E0P329 Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach

  • 3E0P33Z Introduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach

  • 3E0P35Z Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Approach

  • 3E0P36Z Introduction of Nutritional Substance into Female Reproductive, Percutaneous Approach

  • 3E0P37Z Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach

  • 3E0P3BZ Introduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach

  • 3E0P3GC Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach

  • 3E0P3HZ Introduction of Radioactive Substance into Female Reproductive, Percutaneous Approach

  • 3E0P3KZ Introduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach

  • 3E0P3NZ Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach

  • 3E0P3Q0 Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach

  • 3E0P3Q1 Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach

  • 3E0P3SF Introduction of Other Gas into Female Reproductive, Percutaneous Approach

  • 3E0P3TZ Introduction of Destructive Agent into Female Reproductive, Percutaneous Approach

  • 3E0P3VZ Introduction of Hormone into Female Reproductive, Percutaneous Approach

  • 3E0P45Z Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach

  • 3E0P4GC Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach

  • 3E0P704 Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P705 Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P70M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P728 Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P729 Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P73Z Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P76Z Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P77Z Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7BZ Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7GC Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7HZ Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7KZ Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7LZ Introduction of Sperm into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7NZ Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7Q0 Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7Q1 Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7SF Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7TZ Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P7VZ Introduction of Hormone into Female Reproductive, Via Natural or Artificial Opening

  • 3E0P804 Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P805 Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P80M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P828 Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P829 Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P83Z Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P86Z Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P87Z Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8BZ Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8GC Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8HZ Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8KZ Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8NZ Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8SF Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic

  • 3E0P8TZ Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2026 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2025 through September 30, 2026.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.